Fenofibrate

• Recruiting NCT NCT01356290

  Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

  Not yet reported Medical University of Vienna 232 participants Est. completion 2030-04 22 sites Stand-alone
  Other conditions: Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
  View official trial listing →
• Recruiting NCT NCT02823366

  Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

  Not yet reported Xijing Hospital of Digestive Diseases 104 participants Est. completion 2028-12 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Recruiting NCT NCT05365425

  Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

  Not yet reported Seoul National University Bundang Hospital 56 participants Est. completion 2027-12-31 1 site Stand-alone
  Type 2 diabetes Other conditions: Dyslipidemia, Atherosclerosis
  View official trial listing →
• Recruiting NCT NCT05737732

  The Ambient Light Multiple Myeloma Study

  Not yet reported Icahn School of Medicine at Mount Sinai 200 participants Est. completion 2027-06-30 2 sites
  Other conditions: Multiple Myeloma
  View official trial listing →
• Recruiting NCT NCT05749822

  Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

  Not yet reported, Not yet reported Xijing Hospital of Digestive Diseases 104 participants Est. completion 2027-12-31 12 sites Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT05751967

  Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

  Not yet reported Xijing Hospital of Digestive Diseases 150 participants Est. completion 2027-12-01 7 sites Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT06191133

  Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

  Not yet reported Lindsay Ferguson, MD 24 participants Est. completion 2026-12-30 1 site Stand-alone
  Other conditions: Cervical Intraepithelial Neoplasia, Invasive Cervical Cancer
  View official trial listing →
• Recruiting NCT NCT06293417

  To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM

  Not yet reported Korea University Anam Hospital 3958 participants Est. completion 2027-02-01 1 site Stand-alone
  Type 2 diabetes Other conditions: Dyslipidemias
  View official trial listing →
• Recruiting NCT NCT06365424

  Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

  Not yet reported, Not yet reported Xijing Hospital of Digestive Diseases 117 participants Est. completion 2027-04 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT06755151

  Fenofibrate in Primary Biliary Cholangitis: a Real World Study

  Not yet reported Xijing Hospital of Digestive Diseases 300 participants Est. completion 2035-12 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Recruiting NCT NCT06755541

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

  Not yet reported Xijing Hospital of Digestive Diseases 150 participants Est. completion 2035-12 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Recruiting NCT NCT06858332

  Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

  Novartis Pharmaceuticals 2382 participants Est. completion 2027-09-30 20 sites
  Cardiovascular disease
  View official trial listing →
• Recruiting NCT NCT06905054

  Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

  Not yet reported Mayo Clinic 80 participants Est. completion 2028-07-01 1 site Stand-alone
  Other conditions: Primary Sclerosing Cholangitis, Liver Transplant, Complications, PSC, Biliary Strictures
  View official trial listing →
• Recruiting NCT NCT07025005

  Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)

  Not yet reported Tanta University 44 participants Est. completion 2026-09-30 2 sites
  Other conditions: Peripheral Neuropathy, Multiple Myeloma, Neoplasms
  View official trial listing →
• Recruiting NCT NCT07296458

  FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

  Not yet reported Xijing Hospital of Digestive Diseases 132 participants Est. completion 2028-12-31 2 sites Stand-alone
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Recruiting NCT NCT07720232

  Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT

  Not yet reported Jianyin Zhou 180 participants Est. completion 2029-02-18 1 site Stand-alone
  Other conditions: Hypertriglyceridemic Acute Pancreatitis, Acute Pancreatitis, Hypertriglyceridemia-induced, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00000620

  Action to Control Cardiovascular Risk in Diabetes (ACCORD)

  Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sites Stand-alone
  Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
  View official trial listing →
• Completed NCT NCT00006412

  Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 630 participants Est. completion 2003-05 58 sites
  Other conditions: HIV Infections, Lipodystrophy
  View official trial listing →
• Completed NCT NCT00076518

  The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants Est. completion 2005-09 5 sites
  Other conditions: HIV Infections, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00092157

  Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)

  Not yet reported Organon and Co 571 participants Est. completion 2003-03-04
  Other conditions: Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT00092560

  Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

  Not yet reported Organon and Co 587 participants Est. completion 2003-12
  Other conditions: Hypercholesterolemia, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00092573

  Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

  Not yet reported Organon and Co 576 participants Est. completion 2004-11
  Other conditions: Hypercholesterolemia, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00093899

  A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

  Not yet reported Organon and Co 611 participants Est. completion 2005-09
  Other conditions: Hyperlipidemia, Hypercholesterolemia, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00139061

  Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

  Not yet reported Pfizer 128 participants Est. completion 2006-05 26 sites
  Other conditions: Hyperlipidemia
  View official trial listing →
• Terminated NCT NCT00145431

  Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

  Not yet reported Pfizer 41 participants Est. completion 2006-12 27 sites
  Other conditions: Hyperlipoproteinemia Type III
  View official trial listing →
• Completed NCT NCT00158899

  GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

  Not yet reported GlaxoSmithKline 424 participants Est. completion 2006-06 64 sites
  Other conditions: Dyslipidaemias, Dyslipidaemia
  View official trial listing →
• Completed NCT NCT00169559

  Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

  Not yet reported GlaxoSmithKline 250 participants Est. completion 2005-04 50 sites
  Other conditions: Dyslipidaemias
  View official trial listing →
• Completed NCT NCT00186537

  Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

  Not yet reported Stanford University 47 participants Est. completion 2008-09 1 site
  Other conditions: Insulin Resistance, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00195793

  A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

  Not yet reported Abbott 174 participants
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00246376

  Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

  Not yet reported Baylor College of Medicine 221 participants Est. completion 2012-02 1 site Stand-alone
  Cardiovascular disease Other conditions: Heart Diseases, HIV Infections, Hyperlipidemia, Hypertriglyceridemia, Insulin Resistance, Atherosclerosis
  View official trial listing →
• Completed NCT NCT00246636

  Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

  Not yet reported GlaxoSmithKline 167 participants Est. completion 2007-03 Stand-alone
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00251680

  Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

  Not yet reported Takeda 400 participants Est. completion 2007-05 77 sites
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT00252499

  Insulin Resistance in Non-alcoholic Fatty Liver Disease

  Not yet reported US Department of Veterans Affairs 13 participants Est. completion 2010-08 1 site Stand-alone
  Other conditions: Fatty Liver, Insulin Resistance
  View official trial listing →
• Terminated NCT NCT00261352

  GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

  Not yet reported AstraZeneca 1000 participants Est. completion 2006-12 152 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00262964

  Obesity and Nonalcoholic Fatty Liver Disease

  Not yet reported Washington University School of Medicine 51 participants Est. completion 2008-12 1 site Stand-alone
  Other conditions: Non-alcoholic Fatty Liver Disease
  View official trial listing →
• Completed NCT NCT00299884

  Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

  Queen's University 45 participants Est. completion 2006-07 1 site
  Other conditions: Dyslipidemia, Vascular Disease
  View official trial listing →
• Completed NCT NCT00300430

  Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

  Not yet reported Abbott 1911 participants 1 site
  Other conditions: Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia
  View official trial listing →
• Completed NCT NCT00304993

  Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

  Not yet reported Foundation Research, Florida 30 participants Est. completion 2005-02 1 site
  Metabolic syndrome Other conditions: Insulin Resistance
  View official trial listing →
• Completed NCT NCT00309712

  Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

  Not yet reported Intermountain Health Care, Inc. 300 participants Est. completion 2006-09 2 sites
  Other conditions: Type II Diabetes Mellitus, Mixed Dyslipidemia
  View official trial listing →
• Completed NCT NCT00348725

  Acceptability of a Fixed Combination of Fenofibrate and Metformin

  Not yet reported Solvay Pharmaceuticals 69 participants 25 sites
  Other conditions: Dyslipidemia/Glucose Metabolism Disorder
  View official trial listing →
• Completed NCT NCT00349128

  Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

  Not yet reported, Not yet reported Solvay Pharmaceuticals 382 participants 51 sites
  Other conditions: Dyslipidemia/Glucose Metabolism Disorder
  View official trial listing →
• Completed NCT NCT00349284

  A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome

  Not yet reported Solvay Pharmaceuticals 181 participants 43 sites
  Other conditions: Hyperlipidemia Combined
  View official trial listing →
• Completed NCT NCT00349375

  Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

  Not yet reported Solvay Pharmaceuticals 1040 participants Est. completion 2008-09 110 sites Stand-alone
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00349635

  A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.

  Not yet reported Solvay Pharmaceuticals 148 participants 3 sites
  Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT00352183

  Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

  Not yet reported Solvay Pharmaceuticals 450 participants Est. completion 2008-08 67 sites Stand-alone
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT00357500

  Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

  Not yet reported Dana-Farber Cancer Institute 101 participants Est. completion 2013-12 10 sites Stand-alone
  Other conditions: Central Nervous System Tumor, Pediatric, Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
  View official trial listing →
• Completed NCT NCT00359281

  Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

  Not yet reported Aegerion Pharmaceuticals, Inc. 125 participants Est. completion 2007-11 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00361751

  Substrate Cycling in Energy Metabolism

  Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 40 participants Est. completion 2005-05 1 site
  Other conditions: Burns, Insulin Resistance
  View official trial listing →
• Terminated NCT NCT00361868

  Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI

  Not yet reported Solvay Pharmaceuticals 88 participants Est. completion 2007-12 70 sites Stand-alone
  Other conditions: Dyslipidemia, Glucose Metabolism Disorder
  View official trial listing →
• Completed NCT NCT00362206

  Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin

  Not yet reported Solvay Pharmaceuticals 423 participants Est. completion 2008-09 41 sites Stand-alone
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00362323

  Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO

  Not yet reported Solvay Pharmaceuticals 482 participants Est. completion 2009-03 70 sites Stand-alone
  Other conditions: Dyslipidemia/Glucose Metabolism Disorder
  View official trial listing →
• Terminated NCT NCT00362765

  Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study

  Not yet reported, Not yet reported Solvay Pharmaceuticals 8 participants Est. completion 2007-07 3 sites Stand-alone
  Type 2 diabetes Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT00362934

  Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

  Not yet reported Solvay Pharmaceuticals 516 participants Est. completion 2008-08 68 sites Stand-alone
  Other conditions: Hyperlipidemia
  View official trial listing →
• Withdrawn NCT NCT00376285

  Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

  Not yet reported Pfizer
  Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT00385658

  Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

  Not yet reported Novartis 75 participants Est. completion 2007-03 2 sites
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT00400231

  The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

  Not yet reported University of Pennsylvania 124 participants Est. completion 2008-03 1 site
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT00422396

  Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis

  Not yet reported University of Michigan 60 participants Est. completion 2002-04 1 site
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT00458055

  High-Density Lipoprotein (HDL) Treatment Study

  Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 19 participants Est. completion 2007-09 1 site
  Other conditions: Coronary Arteriosclerosis, Hypoalphalipoproteinemias, Genetic Diseases, Inborn
  View official trial listing →
• Completed NCT NCT00459745

  A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

  Not yet reported Shionogi 481 participants Est. completion 2009-07 57 sites Stand-alone
  Other conditions: Combined Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00470262

  Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

  Not yet reported VA Office of Research and Development 27 participants Est. completion 2014-06 1 site
  Metabolic syndrome Other conditions: Prediabetic State
  View official trial listing →
• Withdrawn NCT NCT00483210

  Tissue Lipids and Insulin Resistance

  Not yet reported University of Arkansas
  Other conditions: Tissue Lipid Metabolism
  View official trial listing →
• Completed NCT NCT00487136

  Interaction Between ABT-335, Rosuvastatin and Warfarin

  Not yet reported AstraZeneca 45 participants Est. completion 2007-07 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00490178

  Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

  Not yet reported Solvay Pharmaceuticals 29 participants 3 sites
  Type 2 diabetes Other conditions: Dyslipidemia
  View official trial listing →
• Terminated NCT NCT00491400

  Effect of a Fibrate and a Statin on Endothelial Dysfunction

  Not yet reported Boston University 28 participants Est. completion 2008-12 1 site
  Metabolic syndrome Other conditions: Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00504829

  Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

  Not yet reported Asahi Kasei Therapeutics, Inc. 220 participants Est. completion 2008-07 1 site Stand-alone
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT00542178

  Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

  Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 3472 participants Est. completion 2009-12 7 sites Stand-alone
  Other conditions: Diabetic Retinopathy
  View official trial listing →
• Completed NCT NCT00543647

  Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People

  Not yet reported Solvay Pharmaceuticals 24 participants Est. completion 2003-03 1 site Stand-alone
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT00552747

  Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

  Not yet reported National Heart Institute, Mexico 76 participants Est. completion 2011-01 1 site
  Other conditions: Coronary Heart Disease, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00559962

  Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

  Not yet reported Aegerion Pharmaceuticals, Inc. 260 participants Est. completion 2008-11 15 sites
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00575042

  Use of Fenofibrate for Primary Biliary Cirrhosis

  Not yet reported University of Florida 20 participants Est. completion 2010-08 2 sites Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT00613613

  Fenofibrate and Pharmacogenetic Impact in Dyslipidemia

  University of Minnesota 56 participants Est. completion 2013-12 1 site
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT00616772

  Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

  Not yet reported AbbVie (prior sponsor, Abbott) 682 participants Est. completion 2012-09 124 sites
  Cardiovascular disease Other conditions: Coronary Heart Disease, Dyslipidemia
  View official trial listing →
• Status unknown NCT NCT00627653

  Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function

  Not yet reported National Institute on Aging (NIA) 60 participants Est. completion 2009-12 1 site Stand-alone
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT00632840

  Pharmacological Regulation of Fat Transport in Metabolic Syndrome

  Not yet reported The University of Western Australia 11 participants Est. completion 2007-12
  Cardiovascular disease Other conditions: Obesity, Lipid Disorders, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00639158

  Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

  Not yet reported Abbott 543 participants 118 sites
  Other conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed Dyslipidemia
  View official trial listing →
• Terminated NCT NCT00644592

  LXRA Gene Polymorphisms and Response to Fenofibrate

  Not yet reported University of Florida 11 participants Est. completion 2009-08 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00664859

  12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

  Not yet reported, Not yet reported Asahi Kasei Therapeutics, Inc. 140 participants Est. completion 2009-02 1 site
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT00673881

  ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study

  Not yet reported, Not yet reported Radiant Research 25 participants Est. completion 2009-05 1 site Stand-alone
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT00683176

  Effect of Choline Fenofibrate (SLV348) on Macular Edema

  Not yet reported Abbott Products 110 participants Est. completion 2011-03 21 sites
  Other conditions: Diabetic Macular Edema
  View official trial listing →
• Completed NCT NCT00703482

  A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

  Not yet reported Solvay Pharmaceuticals 278 participants Est. completion 2004-09 3 sites Stand-alone
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT00703690

  MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

  Not yet reported Merck Sharp & Dohme LLC 436 participants Est. completion 2003-12
  Other conditions: Metabolic X Syndrome Dyslipidemia
  View official trial listing →
• Completed NCT NCT00703755

  A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

  Not yet reported Solvay Pharmaceuticals 2288 participants Est. completion 2004-06 101 sites Stand-alone
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT00726856

  Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

  Organon and Co 1200 participants Est. completion 2007-07
  Other conditions: Dyslipidemia
  View official trial listing →
• Withdrawn NCT NCT00732485

  Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate

  Not yet reported, Not yet reported The University of Texas Medical Branch, Galveston Est. completion 2013-12
  Other conditions: Burn
  View official trial listing →
• Completed NCT NCT00745407

  Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

  Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-alone
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT00754039

  Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

  Not yet reported Daiichi Sankyo 129 participants Est. completion 2004-03 10 sites Stand-alone
  Other conditions: Hypercholesterolemia, Hyperlipidemia, Familial Combined
  View official trial listing →
• Completed NCT NCT00775359

  Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

  Not yet reported Ranbaxy Laboratories Limited 24 participants Est. completion 2002-10 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00775827

  Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

  Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2002-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT00794963

  Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

  Not yet reported Northwell Health 8 participants Est. completion 2010-05 1 site Stand-alone
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT00809068

  High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone

  Not yet reported Keogh Institute for Medical Research 20 participants Est. completion 2009-10 1 site
  Other conditions: HDL Cholesterol
  View official trial listing →
• Completed NCT NCT00813527

  Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

  Not yet reported Takeda 213 participants Est. completion 2007-01 36 sites Stand-alone
  Other conditions: Hyperlipidemias
  View official trial listing →
• Terminated NCT NCT00816829

  Effect of Fenofibrate on Sleep Apnea Syndrome

  Not yet reported Solvay Pharmaceuticals 34 participants Est. completion 2008-01 1 site Stand-alone
  Other conditions: Dyslipidemia, Sleep Apnea Syndrome, Overweight, Obesity
  View official trial listing →
• Terminated NCT NCT00819910

  Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)

  Not yet reported Ahmad Slim 41 participants Est. completion 2010-05 1 site Stand-alone
  Other conditions: Hypertriglyceridemia in Type 4 Hyperlipidemia, Non Diabetic Subjects With Normoglycemia
  View official trial listing →
• Completed NCT NCT00839293

  Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

  Not yet reported Abbott 32 participants 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00842712

  Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

  Not yet reported Merck KGaA, Darmstadt, Germany 232 participants Est. completion 2013-07 44 sites
  Other conditions: Carcinoma, Non-Small-Cell Lung
  View official trial listing →
• Status unknown NCT NCT00843661

  Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

  Not yet reported Ospedale di Circolo - Fondazione Macchi 60 participants Est. completion 2012-07 1 site Stand-alone
  Other conditions: HIV, Hyperlipidemia, HIV Infections
  View official trial listing →
• Completed NCT NCT00872599

  The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

  Not yet reported Vanderbilt University 75 participants Est. completion 2012-01 1 site
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT00884819

  Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome

  Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 4 participants Est. completion 2015-02 1 site Stand-alone
  Other conditions: Polycystic Ovary Syndrome
  View official trial listing →
• Completed NCT NCT00891293

  A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

  Not yet reported GlaxoSmithKline 93 participants Est. completion 2008-05 32 sites Stand-alone
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Status unknown NCT NCT00923676

  Treatment of Hyperlipidemia and Sexual Dysfunction

  Not yet reported University of Campania Luigi Vanvitelli 300 participants Est. completion 2016-04 1 site
  Other conditions: Sexual Dysfunction, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00928694

  Fenofibrate Bioequivalence Study (0767-031)

  Not yet reported Merck Sharp & Dohme LLC 14 participants Est. completion 2004-04
  Other conditions: Dyslipidemia
  View official trial listing →
• Available NCT NCT00934258

  Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia

  National Taiwan University Hospital
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00960687

  Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)

  Not yet reported Mutual Pharmaceutical Company, Inc. 54 participants Est. completion 2007-11 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00961116

  Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

  Not yet reported Mutual Pharmaceutical Company, Inc. 54 participants Est. completion 2007-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Available NCT NCT00965315

  A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome

  National Taiwan University Hospital
  Other conditions: Diabetes, CVD
  View official trial listing →
• Completed NCT NCT01003847

  Differential Metabolic Effects of Fenofibrate and Fatty Acid

  Not yet reported Gachon University Gil Medical Center 150 participants Est. completion 2010-09 1 site
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Status unknown NCT NCT01010516

  Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

  Not yet reported University of Ioannina 120 participants 1 site
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT01023750

  Predictors of Response to Fenofibrate

  University of Alabama at Birmingham 39 participants Est. completion 2012-07 1 site
  Other conditions: Hypertriglyceridemia, Insulin Resistance
  View official trial listing →
• Terminated NCT NCT01025492

  Study of Trilipix Effects on Lipids and Arteries

  Not yet reported University of Utah 24 participants Est. completion 2011-03 1 site
  Other conditions: Dyslipidemia
  View official trial listing →
• Withdrawn NCT NCT01030328

  AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis

  Not yet reported Piedmont Healthcare Est. completion 2011-07 1 site
  Other conditions: Coronary Atherosclerosis
  View official trial listing →
• Completed NCT NCT01047501

  Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

  Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sites
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT01047683

  Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

  Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sites
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT01048502

  Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia

  Not yet reported University of Pennsylvania 100 participants Est. completion 2011-05 1 site Stand-alone
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT01099176

  Effects of Hypolipemic Treatment on Adipokines

  Not yet reported Medical University of Silesia 78 participants Est. completion 2009-09 1 site Stand-alone
  Other conditions: Hyperlipidemia, Impaired Fasting Glycemia
  View official trial listing →
• Status unknown NCT NCT01101204

  The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines

  Not yet reported Medical University of Silesia 200 participants Est. completion 2012-12 1 site
  Other conditions: Diabetes, Dyslipidemia, Inflammation, Cytokines
  View official trial listing →
• Completed NCT NCT01109758

  Effects of Fenofibrate on Gene Expression in Healthy Volunteers

  Not yet reported Solvay Pharmaceuticals 26 participants Est. completion 2008-08 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01122355

  Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol

  Not yet reported Yonsei University 240 participants Est. completion 2010-01
  Other conditions: Hypertriglyceridemia With Low HDL-cholesterol
  View official trial listing →
• Withdrawn NCT NCT01141296

  Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

  Not yet reported University of Miami 2 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Terminated NCT NCT01142323

  Pilot Study of Fenofibrate for PSC

  Not yet reported, Not yet reported University of Miami 8 participants Est. completion 2012-12 2 sites Stand-alone
  Other conditions: Primary Sclerosing Cholangitis
  View official trial listing →
• Completed NCT NCT01148004

  The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

  Not yet reported National Institutes of Health Clinical Center (CC) 25 participants Est. completion 2013-07-29 1 site
  Other conditions: HIV, Fenofibrate, Protease Inhibitors, Hypertriglyceridemia, Glucuronosyltransferase
  View official trial listing →
• Completed NCT NCT01211847

  Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

  Not yet reported Essentialis, Inc. 44 participants Est. completion 2011-12
  Other conditions: Hypertriglyceridemia, Dyslipidemia
  View official trial listing →
• Status unknown NCT NCT01265160

  Jiangzhuo Prescription ，Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)

  Guang'anmen Hospital of China Academy of Chinese Medical Sciences 240 participants Est. completion 2011-06 4 sites
  Metabolic syndrome Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT01280604

  Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy

  Not yet reported Kaiser Permanente 66 participants Est. completion 2013-01 1 site Stand-alone
  Other conditions: Hyperlipidemias
  View official trial listing →
• Terminated NCT NCT01289639

  Insulin Resistance in Non-alcoholic Fatty Liver Disease

  Not yet reported VA Office of Research and Development 11 participants Est. completion 2014-08 1 site Stand-alone
  Other conditions: Fatty Liver
  View official trial listing →
• Active, not recruiting NCT NCT01320345

  The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

  Not yet reported University of Sydney 412 participants Est. completion 2026-12 24 sites Stand-alone
  Other conditions: Type 1 Diabetes Mellitus, Diabetic Retinopathy, Diabetic Nephropathies
  View official trial listing →
• Completed NCT NCT01353404

  Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)

  Not yet reported Samyang Biopharmaceuticals Corporation 24 participants Est. completion 2011-08 1 site Stand-alone
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT01414803

  Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia

  Not yet reported Yonsei University 180 participants Est. completion 2011-04 1 site Stand-alone
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT01426438

  Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

  Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 99 participants Est. completion 2013-10 14 sites Stand-alone
  Other conditions: HIV-1 Infection
  View official trial listing →
• Completed NCT NCT01462877

  A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

  Not yet reported Abbott 506 participants Est. completion 2014-03 1 site
  Cardiovascular disease Other conditions: Dyslipidemias, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT01472380

  A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz

  Not yet reported Mutual Pharmaceutical Company, Inc. 30 participants Est. completion 2012-01 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01492361

  A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

  Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sites
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT01501435

  To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra

  Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-06 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01509196

  A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet

  Not yet reported Hanmi Pharmaceutical Company Limited 28 participants Est. completion 2012-02 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01539616

  A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

  Not yet reported Zydus Lifesciences Limited 109 participants Est. completion 2012-08 18 sites
  Other conditions: Hypertriglyceridemia, Dyslipidemia
  View official trial listing →
• Terminated NCT NCT01574131

  Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

  Not yet reported The University of Texas Medical Branch, Galveston 3 participants Est. completion 2016-02 1 site
  Other conditions: Second or Third Degree Burns
  View official trial listing →
• Completed NCT NCT01594983

  A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

  Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2013-07 32 sites Stand-alone
  Other conditions: Non Familial Chylocmicronemia Syndrome (Non-FCS)
  View official trial listing →
• Completed NCT NCT01666041

  Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

  Not yet reported Gachon University Gil Medical Center 120 participants Est. completion 2013-07 1 site
  Other conditions: Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT01674712

  A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

  Not yet reported Abbott 575 participants Est. completion 2013-10 69 sites Stand-alone
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT01723735

  Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects

  Not yet reported Sanofi 79 participants Est. completion 2013-07 2 sites Stand-alone
  Other conditions: Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT01752842

  Lipid Biomarkers for Diabetic Heart Disease

  Not yet reported Washington University School of Medicine 70 participants Est. completion 2018-02-23 1 site Stand-alone
  Other conditions: Type II Diabetes Mellitus, Diabetes Complications
  View official trial listing →
• Completed NCT NCT01767610

  Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

  Not yet reported Hanlim Pharm. Co., Ltd. 24 participants Est. completion 2013-07 1 site Stand-alone
  Other conditions: Healthy Male Volunteers
  View official trial listing →
• Completed NCT NCT01878227

  Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia

  Not yet reported Zhejiang University 420 participants Est. completion 2011-06 1 site
  Other conditions: Hyperlipoproteinemia
  View official trial listing →
• Completed NCT NCT01927315

  Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

  Not yet reported University of Padova 41 participants Est. completion 2019-12 1 site Stand-alone
  Other conditions: Diabetes, Diabetic Retinopathy
  View official trial listing →
• Status unknown NCT NCT01956201

  Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

  Not yet reported Chong Kun Dang Pharmaceutical 476 participants Est. completion 2016-08 30 sites Stand-alone
  Other conditions: Mixed Hyperlipidemia
  View official trial listing →
• Terminated NCT NCT01965834

  Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

  Not yet reported University of Miami 6 participants Est. completion 2016-07-01 1 site Stand-alone
  Other conditions: Multiple Myeloma
  View official trial listing →
• Status unknown NCT NCT01974544

  Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

  Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT02015988

  Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome

  Not yet reported Koval' O., MD 60 participants Est. completion 2017-05 1 site Stand-alone
  Type 2 diabetes Other conditions: Acute Coronary Syndrome, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT02023879

  Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)

  Not yet reported Sanofi 233 participants Est. completion 2017-06-30 43 sites Stand-alone
  Other conditions: Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT02066207

  CKD-337 Drug Interaction Study

  Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2014-05-29 1 site Stand-alone
  Other conditions: Dyslipidemia (Fredrickson Type Ⅱa), Dyslipidemia (Fredrickson Type Ⅱb)
  View official trial listing →
• Withdrawn NCT NCT02069717

  Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

  Daewoong Pharmaceutical Co. LTD. Est. completion 2014-09 1 site
  Metabolic syndrome
  View official trial listing →
• Status unknown NCT NCT02079376

  The DIAMOND® for the Treatment of Type 2 Diabetes

  Not yet reported MetaCure Limited 45 participants Est. completion 2016-12 13 sites Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02153879

  Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment

  Not yet reported Institut Investigacio Sanitaria Pere Virgili 30 participants Est. completion 2013-12 1 site Stand-alone
  Type 2 diabetes Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT02158273

  Medication Development in Alcoholism: Investigating PPAR Agonists

  Not yet reported The Scripps Research Institute 50 participants Est. completion 2016-04 1 site
  Other conditions: Alcoholism
  View official trial listing →
• Completed NCT NCT02166593

  Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin

  Not yet reported Yooyoung Pharmaceutical Co., Ltd. 302 participants Est. completion 2018-01 1 site Stand-alone
  Other conditions: Combined Dyslipidemia
  View official trial listing →
• Status unknown NCT NCT02232360

  Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone

  Not yet reported Gachon University Gil Medical Center 106 participants Est. completion 2020-12 6 sites Stand-alone
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT02250976

  The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

  Not yet reported Hanlim Pharm. Co., Ltd. 41 participants Est. completion 2014-10 1 site Stand-alone
  Other conditions: Healthy Male Volunteers
  View official trial listing →
• Completed NCT NCT02262143

  Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

  Not yet reported IlDong Pharmaceutical Co Ltd 362 participants Est. completion 2017-06 1 site Stand-alone
  Other conditions: Mixed Dyslipidemias
  View official trial listing →
• Completed NCT NCT02306889

  Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

  Not yet reported Ranbaxy Laboratories Limited 48 participants Est. completion 2010-04 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02306902

  Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

  Not yet reported Ranbaxy Laboratories Limited 24 participants Est. completion 2010-04 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT02314533

  Evaluate the Efficacy of Fenofibrate on Microalbuminuria

  Not yet reported Beijing Chao Yang Hospital 200 participants Est. completion 2016-12 Stand-alone
  Other conditions: Microalbuminuria
  View official trial listing →
• Completed NCT NCT02354976

  A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

  Not yet reported AstraZeneca 78 participants Est. completion 2016-05-26 4 sites
  MASLD Other conditions: Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT02422030

  CKD-337(2) Drug-drug Interaction Study

  Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2015-04-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT02452255

  Fenofibrate and Propranolol in Burn Patients

  Not yet reported, Not yet reported The University of Texas Medical Branch, Galveston 18 participants Est. completion 2019-07-12 1 site
  Other conditions: Burn
  View official trial listing →
• Completed NCT NCT02455336

  Fenofibrate Treatment in SCI

  Not yet reported, Not yet reported VA Office of Research and Development 23 participants Est. completion 2018-08-01 2 sites Stand-alone
  Other conditions: Spinal Cord Injury, Dyslipidemia
  View official trial listing →
• Completed NCT NCT02584504

  Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin

  Not yet reported Sanofi 163 participants Est. completion 2018-01-09 30 sites Stand-alone
  Other conditions: Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT02642159

  Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

  Not yet reported Sanofi 413 participants Est. completion 2017-05-15 119 sites
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT02651753

  A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

  Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2016-05
  Other conditions: Dyslipidemia
  View official trial listing →
• Completed NCT NCT02781584

  Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

  Not yet reported Gilead Sciences 220 participants Est. completion 2020-12-17 13 sites Stand-alone
  MASHMASLD
  View official trial listing →
• Completed NCT NCT02823353

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

  Not yet reported Xijing Hospital of Digestive Diseases 117 participants Est. completion 2022-06 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT02886299

  Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis

  Not yet reported Cairo University 60 participants Est. completion 2016-01
  Other conditions: Fenofibrate/Simvastatin Comparison
  View official trial listing →
• Completed NCT NCT02890992

  An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

  Not yet reported Sanofi 42 participants Est. completion 2019-02-22 16 sites Stand-alone
  Other conditions: Hypercholesterolaemia
  View official trial listing →
• Completed NCT NCT02891408

  Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

  Not yet reported Gilead Sciences 74 participants Est. completion 2019-05-13 5 sites Stand-alone
  MASH
  View official trial listing →
• Withdrawn NCT NCT02965911

  Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

  Not yet reported, Not yet reported Beijing 302 Hospital Est. completion 2021-09-08 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT02971423

  Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects

  Not yet reported Entasis Therapeutics 124 participants Est. completion 2017-06-01 1 site
  Other conditions: Acinetobacter Baumannii Infection
  View official trial listing →
• Completed NCT NCT02984982

  Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

  Not yet reported Sanofi 206 participants Est. completion 2018-07-27 39 sites Stand-alone
  Other conditions: Hypercholesterolemia, Acute Coronary Syndrome
  View official trial listing →
• Completed NCT NCT03001817

  Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

  Not yet reported Kowa Research Institute, Inc. 551 participants Est. completion 2019-06-24 220 sites
  Other conditions: Severe Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT03011450

  Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

  Not yet reported Kowa Research Institute, Inc. 471 participants Est. completion 2019-07-05 241 sites
  Other conditions: Severe Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT03230916

  A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)

  Not yet reported Merck Sharp & Dohme LLC 47 participants Est. completion 2020-08-11 33 sites
  Other conditions: Suspected or Documented Gram-negative Bacterial Infection
  View official trial listing →
• Completed NCT NCT03346187

  A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

  Not yet reported Chong Kun Dang Pharmaceutical 60 participants Est. completion 2017-06-13 1 site Stand-alone
  Other conditions: Dyslipidemias
  View official trial listing →
• Completed NCT NCT03382756

  A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

  Not yet reported Chong Kun Dang Pharmaceutical 16 participants Est. completion 2017-11-07 1 site
  Other conditions: Dyslipidemias
  View official trial listing →
• Completed NCT NCT03439345

  Lowering Events in Non-proliferative Retinopathy in Scotland

  Not yet reported University of Oxford 1151 participants Est. completion 2024-02-16 16 sites Stand-alone
  Other conditions: Diabetic Retinopathy
  View official trial listing →
• Completed NCT NCT03510715

  An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

  Not yet reported Sanofi 18 participants Est. completion 2020-02-17 10 sites Stand-alone
  Other conditions: Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT03510884

  An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

  Not yet reported Sanofi 153 participants Est. completion 2022-08-05 43 sites Stand-alone
  Other conditions: Hypercholesterolaemia
  View official trial listing →
• Completed NCT NCT03515213

  Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

  Not yet reported University of California, Irvine 10 participants Est. completion 2021-08-31 1 site
  Other conditions: Huntington Disease
  View official trial listing →
• Status unknown NCT NCT03557983

  Evaluation of Fenofibrate on Radiation-induced Skin Injury

  Not yet reported Second Affiliated Hospital of Soochow University 30 participants Est. completion 2020-04-13 1 site Stand-alone
  Other conditions: Radiodermatitis
  View official trial listing →
• Completed NCT NCT03586674

  Fibrates in Pediatric Cholestasis

  Not yet reported Hoda A. Atta 50 participants Est. completion 2018-06-20 2 sites
  Other conditions: Chronic Cholestasis
  View official trial listing →
• Completed NCT NCT03615534

  Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

  Not yet reported Lewai Sharki Abdulaziz, MSc PhD 161 participants Est. completion 2015-10-30 2 sites
  Other conditions: Atherogenic Dyslipidemia, Obesity Associated Disorder
  View official trial listing →
• Completed NCT NCT03618797

  A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

  Not yet reported Hanlim Pharm. Co., Ltd. 347 participants Est. completion 2018-05 Stand-alone
  Other conditions: Complex-dyslipidemia
  View official trial listing →
• Completed NCT NCT03829514

  Fenofibrate in Type 2 Diabetes

  Not yet reported Medical University of South Carolina 10 participants Est. completion 2020-03-04 1 site Stand-alone
  Other conditions: Diabetes Mellitus, Type II
  View official trial listing →
• Status unknown NCT NCT03869931

  Effects of Fenofibrate Therapy in Diabetic Nephropathy

  Not yet reported Singapore General Hospital 300 participants Est. completion 2021-04-30 1 site Stand-alone
  Other conditions: Diabetes Mellitus, Diabetic Nephropathies
  View official trial listing →
• Status unknown NCT NCT03874260

  Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

  Not yet reported Daewon Pharmaceutical Co., Ltd. 180 participants Est. completion 2020-03-31 1 site Stand-alone
  Other conditions: Dyslipidemias
  View official trial listing →
• Status unknown NCT NCT04140201

  Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

  Not yet reported Alaa Hassan ElBaz 80 participants Est. completion 2020-08
  Other conditions: Diabetic Retinopathy
  View official trial listing →
• Status unknown NCT NCT04394949

  Securing Employment and Economic Keys to Stability for Persons With Disabilities

  Not yet reported Communication Institute International, Inc. 190 participants Est. completion 2025-09-30 1 site
  Other conditions: Employment
  View official trial listing →
• Completed NCT NCT04418180

  Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants

  Not yet reported Mansoura University
  Other conditions: Neonatal Jaundice
  View official trial listing →
• Completed NCT NCT04517396

  FEnofibRate as a Metabolic INtervention for COVID-19

  Not yet reported University of Pennsylvania 701 participants Est. completion 2022-03-30 1 site Stand-alone
  Other conditions: Covid19
  View official trial listing →
• Completed NCT NCT04528212

  Fenofibrate Versus Curcumin in Type 2 Diabetic Patients

  Not yet reported Rehab Werida 60 participants Est. completion 2021-12-01 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT04650152

  Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)

  Abbott 1000 participants Est. completion 2021-11-12 63 sites
  Metabolic syndrome Other conditions: Hypertriglyceridemia
  View official trial listing →
• Active, not recruiting NCT NCT04661358

  Fenofibrate for Prevention of DR Worsening

  Not yet reported Jaeb Center for Health Research 563 participants Est. completion 2029-12 66 sites Stand-alone
  Other conditions: Diabetic Retinopathy
  View official trial listing →
• Status unknown NCT NCT04661930

  Fenofibrate for Patients With COVID-19 Requiring Hospitalization

  Not yet reported Yaakov Nahmias 55 participants Est. completion 2022-07-01 3 sites Stand-alone
  Other conditions: Corona Virus Disease (COVID-19), Respiratory Distress Syndrome, SARS-CoV-2 Infection
  View official trial listing →
• Status unknown NCT NCT04868019

  Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial

  Not yet reported Shaheed Zulfiqar Ali Bhutto Medical University 60 participants Est. completion 2022-02 Stand-alone
  Other conditions: Hyperbilirubinemia, Neonatal
  View official trial listing →
• Status unknown NCT NCT04882293

  Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

  Not yet reported Laboratorios Silanes S.A. de C.V. 78 participants Est. completion 2022-05 1 site Stand-alone
  Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT04885153

  Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume

  Not yet reported Universitas Indonesia 36 participants Est. completion 2017-07-01 Stand-alone
  Other conditions: Diabetic Retinopathy, Dyslipidemias, Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT04907084

  Serine and Fenofibrate Study in Patients With MacTel Type 2

  Not yet reported The Lowy Medical Research Institute Limited 89 participants Est. completion 2024-09-30 9 sites Stand-alone
  Other conditions: Macular Telangiectasia Type 2
  View official trial listing →
• Completed NCT NCT04929379

  A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

  Not yet reported Alessandro Doria 35 participants Est. completion 2026-10-15 4 sites Stand-alone
  Other conditions: Diabetic Nephropathies
  View official trial listing →
• Completed NCT NCT04998981

  A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

  Not yet reported Kowa Company, Ltd. 353 participants Est. completion 2023-02-02 33 sites
  Other conditions: Hyperlipidemia
  View official trial listing →
• Completed NCT NCT05080192

  Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate

  University of Pennsylvania 12 participants Est. completion 2022-05-10 1 site
  Other conditions: Covid19
  View official trial listing →
• Status unknown NCT NCT05256758

  Oxford - Fibrates in Aortic Stenosis

  Not yet reported University of Oxford 67 participants Est. completion 2022-03-31 1 site Stand-alone
  Other conditions: Aortic Valve Stenosis
  View official trial listing →
• Status unknown NCT NCT05498090

  Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome

  Not yet reported University of Colorado, Denver 44 participants Est. completion 2025-08-30 1 site Stand-alone
  Other conditions: Klinefelter Syndrome
  View official trial listing →
• Terminated NCT NCT05514119

  A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation

  Not yet reported Mayo Clinic 6 participants Est. completion 2024-12-01 1 site Stand-alone
  Other conditions: Liver Transplant
  View official trial listing →
• Active, not recruiting NCT NCT05537948

  Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

  Not yet reported National Medical Research Center for Therapy and Preventive Medicine 59 participants Est. completion 2025-01-31 1 site
  Other conditions: Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder, Immunosuppression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Statins
  View official trial listing →
• Completed NCT NCT05542147

  Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

  Not yet reported Mario Luca Morieri 200 participants Est. completion 2024-11-30 1 site Stand-alone
  Type 2 diabetesCardiovascular disease Other conditions: Pharmacogenomic Drug Interaction
  View official trial listing →
• Completed NCT NCT05753267

  Fenofibrate in Ulcerative Colitis

  Not yet reported, Not yet reported Tanta University 60 participants Est. completion 2025-09-20 1 site
  Other conditions: Inflammatory Bowel Diseases
  View official trial listing →
• Completed NCT NCT05781698

  Repurposing Fenofibrate in Modulating AMPK/NLRP3 Inflammasome in Patients With Ulcerative Colitis

  Not yet reported Tanta University 70 participants Est. completion 2024-04-20 1 site
  Other conditions: Inflammatory Bowel Diseases
  View official trial listing →
• Completed NCT NCT05813145

  Fenofibrate Role in Breast Cancer Patients

  Not yet reported Damanhour University 50 participants Est. completion 2024-08-05 1 site
  Other conditions: Breast Cancer
  View official trial listing →
• Status unknown NCT NCT05883865

  Safety Study of Fenofibrate During Pregnancy

  First People's Hospital of Hangzhou 250 participants Est. completion 2025-12-01 1 site
  Other conditions: Severe Hypertriglyceridemia During Pregnancy
  View official trial listing →
• Status unknown NCT NCT05909800

  Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.

  Not yet reported Medical University of Warsaw 102 participants Est. completion 2024-07 2 sites
  Other conditions: Diabetes Mellitus, Type 1
  View official trial listing →
• Completed NCT NCT06155331

  Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

  Not yet reported Tanta University 44 participants Est. completion 2025-01-01 1 site
  Other conditions: Breast Cancer Stage 2 and 3
  View official trial listing →
• Active, not recruiting NCT NCT06174402

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

  Not yet reported, Not yet reported Han Ying 184 participants Est. completion 2026-12-31 12 sites Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Status unknown NCT NCT06346743

  Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Neonatal Jaundice.

  Not yet reported, Not yet reported Muhammad Zark 156 participants Est. completion 2024-08 1 site Stand-alone
  Other conditions: Physiological Neonatal Jaundice, Physiological Hyperbilirubinaemia
  View official trial listing →
• Completed NCT NCT06451900

  Role of Fenofibrate in Neonatal Jaundice

  Not yet reported Ain Shams University 75 participants Est. completion 2023-11-30 1 site Stand-alone
  Other conditions: Neonatal Jaundice
  View official trial listing →
• Completed NCT NCT06591455

  A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

  Not yet reported Han Ying 30 participants Est. completion 2025-08-18 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Status unknown NCT NCT06623539

  Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

  Not yet reported Yokohama City University 360 participants Est. completion 2026-03 1 site Stand-alone
  Other conditions: Non Alcoholic Fatty Liver Disease
  View official trial listing →
• Not yet recruiting NCT NCT06796660

  Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients

  Not yet reported Liu Zhanghong 70 participants Est. completion 2027-12-31 3 sites Stand-alone
  Other conditions: Renal Insufficiency, Chronic
  View official trial listing →
• Active, not recruiting NCT NCT07104201

  Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

  Not yet reported Xijing Hospital of Digestive Diseases 15 participants Est. completion 2035-03 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Not yet recruiting NCT NCT07572552

  Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With Sepsis

  Not yet reported Tanta University 66 participants Est. completion 2028-04 Stand-alone
  Other conditions: Sepsis
  View official trial listing →
• Not yet recruiting NCT NCT07774741

  Comparison Of Fenofibrate Vs Phenobarbitone As Adjunct To Phototherapy In Reducing Total Serum Bilirubin In Indirect Hyperbilirubinemia In Neonates

  Not yet reported Rubab Fatima 70 participants Est. completion 2027-10 Stand-alone
  Other conditions: Jaundice, Neonatal
  View official trial listing →
• Active, not recruiting NCT NCT07907965

  A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease

  Not yet reported Beijing University of Chinese Medicine 15 participants Est. completion 2026-10-27 1 site Stand-alone
  Chronic kidney diseaseType 2 diabetes Other conditions: Albuminuria
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT04929379

No related coverage yet.